Status:
COMPLETED
Vitrectomy for Branch Retinal Vein Occlusion
Lead Sponsor:
Shinjo Ophthalmologic Institute
Conditions:
Vitrectomy
Eligibility:
All Genders
45-86 years
Brief Summary
To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occ...
Eligibility Criteria
Inclusion
- duration of symptoms lasting 27 weeks
Exclusion
- vitreous hemorrhage
- severe cataract
- biomicroscopic vitreomacular traction and epiretinal membrane
- previous vitreoretinal surgery
- other ocular diseases that could contribute to visual loss.
- patients with macular branch vein occlusion
- patients with a history of previous grid laser photocoagulation
Key Trial Info
Start Date :
July 1 1995
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00685490
Start Date
July 1 1995
End Date
November 1 2006
Last Update
May 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shinjo Ophthalmologic Institute
Miyazaki, Miyazaki, Japan, 880-0035